Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | Pharmaceutical Technology | Best Researcher Award

Prof. Dr. Neslihan Üstündağ Okur | University of Health Sciences | Turkey

Prof. Dr. Neslihan Üstündağ Okur is a distinguished scholar in pharmaceutical technology with a career dedicated to advancing innovative drug delivery systems. She earned her Bachelor of Pharmacy, Master’s degree, and PhD from Ege University, focusing her research on microemulsions, transdermal formulations, and ocular nano-carrier systems. Her academic journey has included roles as Research Assistant, Assistant Professor, Associate Professor, and currently Professor at the University of Health Sciences, Faculty of Pharmacy, where she also serves as Dean and Head of the Pharmaceutical Technology Department. She has held significant administrative positions at Istanbul Medipol University and has contributed extensively to the development of pharmaceutical formulations including microemulsions, solid lipid nanoparticles, in situ gels, dermal and ocular delivery systems, and sustained release technologies. Prof. Dr. Okur is actively engaged with professional organizations such as TÜFTAD, CRS, and ATINER. With a strong citation record and international recognition, she continues to shape pharmaceutical sciences globally.

Publication Profile

Google scholar

Educational Background

Prof. Dr. Neslihan Üstündağ Okur has pursued an impressive academic journey in pharmaceutical technology, building a strong foundation at Ege University. She completed her Bachelor of Pharmacy at the Faculty of Pharmacy, where she developed a deep interest in innovative drug delivery systems. Her academic path continued with a Master’s degree in Pharmaceutical Technology, where she focused on the in vitro and in vivo evaluation of transdermal microemulsion formulations containing naproxen, a study that highlighted her dedication to advancing therapeutic applications. She further strengthened her expertise by completing her doctoral research at the same institution, where her thesis explored the in vitro and in vivo evaluation of ocular nano-carrier systems containing antibiotics, contributing valuable insights into ocular drug delivery. This comprehensive academic background has laid the groundwork for her distinguished career, equipping her with advanced knowledge and innovative approaches in pharmaceutical sciences.

Professional Experience

Prof. Dr. Neslihan Üstündağ Okur has built an extensive career in pharmaceutical technology through progressive academic and administrative roles. She is currently serving as Professor at the University of Health Sciences, Faculty of Pharmacy, where she holds dual leadership positions as Dean of the Faculty of Pharmacy and Head of the Pharmaceutical Technology Department. Prior to this, she contributed as Associate Professor at the same institution, also leading the department with dedication. Her career includes valuable service at Istanbul Medipol University, where she held positions as Associate Professor and Vice Dean, and earlier as Assistant Professor and Head of the Pharmaceutical Technology Department. She began her academic journey at Ege University, serving first as a Research Assistant and later as Research Assistant with a doctoral focus, gaining deep expertise in drug delivery systems and pharmaceutical formulations. Throughout her career, she has demonstrated leadership, innovation, and a strong commitment to advancing pharmaceutical sciences.

Research Focus

Prof. Dr. Neslihan Üstündağ Okur’s research focus lies predominantly in the field of pharmaceutical technology, with particular emphasis on advanced drug delivery systems and innovative therapeutic formulations. Her work explores a wide range of drug carriers including polymeric systems, nano-structured lipid carriers, solid lipid nanoparticles, microemulsions, in situ gels, and composite films, targeting enhanced dermal, transdermal, and ocular drug delivery. She has made significant contributions to wound management through the development of polymeric carriers and novel dermal applications, as well as to ocular therapy with nanostructured platforms designed to improve bioavailability and treatment efficacy. Her studies further extend to anti-inflammatory and antifungal drug formulations, the use of stimuli-responsive nanoparticles, and nanotheranostic platforms for diagnostic and therapeutic purposes. By integrating in vitro and in vivo evaluations, she bridges experimental research with clinical applications, positioning her expertise at the intersection of pharmaceutical innovation, nanotechnology, and targeted drug delivery solutions.

Publication Top Notes

Recent trends on wound management: New therapeutic choices based on polymeric carriers
Year: 2020
Citations: 349

Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses
Year: 2016
Citations: 230

Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities
Year: 2021
Citations: 180

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations
Year: 2011
Citations: 149

Conclusion

Prof. Dr. Neslihan Üstündağ Okur is highly suitable for the Research for Best Researcher Award. Her innovative work in advanced drug delivery systems positions her as a leading figure whose contributions merit this recognition.

Dr Ashwin Kuchekar | Pharmaceutics | Best Researcher Award

Ashwin Kuchekar | Pharmaceutics | Best Researcher Award

Professor Ashwin Kuchekar School of Health Sciences and Technology at India.

Dr. Ashwin Kuchekar is the Associate Dean (Academic and Faculty Affairs) and a Professor at the School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune. With extensive experience in both academia and industry, he focuses on enhancing research, management, and administration within the pharmaceutical sector. His expertise spans pharmaceutical formulation, development, and quality by design. Dr. Kuchekar is committed to bridging the gap between industry and academia through innovative teaching and robust industry partnerships.

PUBLICATION PROFILE:

google scholar

Education:

  • Ph.D. in Pharmaceutics (Pharmaceutical Sciences)
    Bharati Vidyapeeth University, Pune, India (2010-2015)
    Dissertation: Development and Evaluation of Targeted Polymeric Micellar Drug Delivery System
    Guide: Prof. Atmaram Pawar
  • Master of Pharmacy (Pharmaceutics)
    R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur, North Maharashtra University, India (2009)
    Dissertation: Formulation and Evaluation of Chronotherapeutic Drug Delivery Systems
    Guide: Dr. Surendra Gattani
  • Bachelor of Pharmacy
    Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, India (2007)
  • HSC
    Sadguru Gadge Maharaj College, Vidyanagar, Karad, Kolhapur Board, India (2003)
  • SSC
    Holy Family Convent High School, Vidyanagar, Karad, Kolhapur Board, India (2001)

Experience:

  • Associate Dean (Academic and Faculty Affairs) & Professor
    Dr. Vishwanath Karad MIT World Peace University, Pune (June 2023 – Present)
    Responsibilities include teaching B. Pharm. and M. Pharm. students, guiding research projects, managing the pilot plant, and overseeing training, placement, and industry partnerships.
  • Associate Professor
    Dr. Vishwanath Karad MIT World Peace University, School of Pharmacy, Pune (June 2019 – June 2023)
  • Lecturer – Pharmaceutics
    Progressive Education Society’s, Modern College of Pharmacy (For Ladies), Moshi, Pune (Nov 2009 – Aug 2010)
  • Industrial Experience:
    Innovation and Development at Abbott Healthcare Pvt. Ltd., Mumbai (Sep 2016 – Jun 2019)
    Formulation and Development at Lupin Research Park, Pune (Aug 2014 – Sep 2016)
    Formulation and Development at Piramal Health Care, Mumbai (May 2009 – Nov 2009)
    Formulation and Development at Nu-Life Pharmaceuticals, Pune (May 2006 – Jun 2006)

Research Focus:

Dr. Ashwin Kuchekar’s research is dedicated to advancing the field of pharmaceutics with a focus on innovative drug delivery systems and formulation development. His work encompasses a range of topics within pharmaceutical sciences, emphasizing the creation of novel technologies and methodologies to improve therapeutic efficacy and patient outcomes. Key areas of his research include:

  • 1. Drug Delivery Systems
  • Dr. Kuchekar explores cutting-edge methods for optimizing drug delivery, including:
  • Orally Disintegrating Tablets: Development and evaluation of tablets that rapidly dissolve in the mouth, enhancing patient compliance.
  • Nanoparticle-Based Delivery: Use of nanoparticles to improve the solubility and bioavailability of drugs, and to target specific sites within the body.
  • 2. Innovative Formulation Technologies
  • His research investigates novel formulation techniques to address challenges in pharmaceutical development, such as:
  • Cocrystallization: Enhancing drug properties through the formation of cocrystals to improve solubility and stability.
  • Hydrotropic Solubilization: Using hydrotropic agents to increase the solubility of poorly soluble drugs.
  • 3. Anticoagulant Research
  • Dr. Kuchekar has made significant contributions to the field of anticoagulants, including:
  • In Vivo Evaluation: Assessing the anticoagulant activity of new formulations and technologies to improve treatment outcomes for patients at risk of thromboembolic events.
  • 4. Green and Sustainable Chemistry
  • He focuses on environmentally friendly approaches, such as:
  • Green Synthesized Nanoparticles: Development of silver nanoparticles using plant extracts, contributing to sustainable practices in pharmaceutical research.
  • 5. Pediatric Drug Delivery
  • Dr. Kuchekar is also involved in research aimed at improving drug delivery systems for pediatric patients, addressing unique challenges in formulation and administration.
  • Dr. Kuchekar’s work is characterized by its emphasis on practical, real-world applications of pharmaceutical science, aiming to bridge the gap between research innovations and clinical practice to benefit patients and healthcare providers alike.

Research Interests:

  • Pharmaceutics and Drug Delivery Systems: Development and optimization of novel drug delivery systems, including targeted and controlled-release formulations. This includes the use of polymeric micelles, cocrystallization technology, and chronotherapeutic systems to improve drug efficacy and patient compliance.
  • Nanotechnology in Medicine: Application of nanotechnology in pharmaceutical formulations, such as green synthesis of nanoparticles for therapeutic use, and the development of dry powder inhalers.
  • Anticoagulant and Cardiovascular Drugs: Research on the formulation and evaluation of anticoagulant drugs, including the development of innovative dosage forms like matrix tablets and cocrystals to enhance their therapeutic potential.
  • Oncology: Exploration of new treatment strategies for various cancers, including triple-negative breast cancer, focusing on novel therapeutic approaches and their mechanisms of action.
  • Precision Medicine: Implementation of precision medicine approaches in the treatment of allergic rhinitis and other conditions, emphasizing individualized therapy based on patient-specific factors.
  • Skin Rejuvenation and Retinoids: Study of novel drug delivery systems for retinoids to improve skin rejuvenation and address age-related skin changes.
  • mRNA Vaccine Development: Investigation of lipid nanoparticles and other delivery systems in the development and optimization of mRNA vaccines for infectious diseases and other medical applications.

Publications:

  1. Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery
  2. Pharmaceutical Quality by Design: A new approach in product development
  3. Screening of factors using Plackett Burman design in the preparation of capecitabine-loaded nano polymeric micelles
  4. Six sigma: process of understanding the control and capability of ranitidine hydrochloride tablet
  5. Self microemulsifying drug delivery system: a novel approach for hydrophobic drugs
  6. Emulgel approach to formulation development: a review
  7. Capecitabine loaded polymeric micelles: Formulation, characterization and cytotoxicity study
  8. Development of ranolazine loaded floating biomaterial gellan beads using Box-Behnken factorial designHydrotropic solubilization: an emerging approach
  9. Hydrotropic solubilization: an emerging approach
  10. Polymeric micelles: a novel approach towards nano-drug delivery system